Cargando…
Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
Using examples from recent FDA regulatory proceedings, Jonas Hines and colleagues critique the medical device premarket review and identify eight weaknesses in the process that should be remedied.
Autores principales: | Hines, Jonas Zajac, Lurie, Peter, Yu, Eunice, Wolfe, Sidney |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903853/ https://www.ncbi.nlm.nih.gov/pubmed/20634922 http://dx.doi.org/10.1371/journal.pmed.1000280 |
Ejemplares similares
-
Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019) -
Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China
por: Kramer, Daniel B., et al.
Publicado: (2013) -
Ghostwriting at Elite Academic Medical Centers in the United States
por: Lacasse, Jeffrey R., et al.
Publicado: (2010) -
Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023) -
The state of the antivaccine movement in the United States: A focused examination of nonmedical exemptions in states and counties
por: Olive, Jacqueline K., et al.
Publicado: (2018)